MÆDICA - a Journal of Clinical Medicine Logo
  • Home
  • Profile
  • Standards
    • Types of articles
    • Instructions for authors
    • Editing rules (peer-review protocol)
    • Official Journal’s protocols
  • Editorial Council
  • Peer-review TEAM
  • How to
  • Menu

Author archives

  • About
  • Latest Posts

Ikhwan RINALDI

Latest posts by Ikhwan RINALDI (see all)

  • Hormonal Treatment for Symptomatic Bone Marrow Metastasis in Breast Cancer Patients - October 1, 2018

Articles signed on MÆDICA, JCM:

Hormonal Treatment for Symptomatic Bone Marrow Metastasis in Breast Cancer Patients

SELECT ISSUE


MÆDICA - a Journal of Clinical Medicine | Vol. 13, nr. 3, 2018
CNCSIS - CMR - B+ OBBCSSR

Members Area


Hormonal Treatment for Symptomatic Bone Marrow Metastasis in Breast Cancer Patients

Rahmat CAHYANUR and Ikhwan RINALDI

ABSTRACT

Breast cancer is the most common cancer in females worldwide and also in Indonesia. Symptomatic bone marrow metastasis is an uncommon presentation of metastatic breast cancer patient. A retrospective study showed that, out of 12970 patients with breast cancer, only 0.17% had symptomatic bone marrow metastasis. Management of patients with bone marrow metastasis also creates dilemma for the clinician. Risk and benefit from treatment should be discussed and carefully considered.
We describe here a case report of a 58-year-old female patient with pancytopenia, who had a history of breast cancer four years before. A PET CT Scan showed multiple vertebrae bone metastasis. Bone marrow biopsy revealed marrow infiltration of metastasis breast cancer in bone marrow. This patient received hormonal treatment, which resulted in promising results for four months. Unfortunately, the patient did not come for control regularly and died due to hepatic failure caused by liver metastasis.
Keywords: breast cancer, bone marrow, metastasis, hormonal treatment.

Full text | PDF



plic-mail[email protected]

 Terms and conditions

© MÆDICA - a Journal of Clinical Medicine - All rights reserved